Country: United States
Language: English
Source: NLM (National Library of Medicine)
PREDNISOLONE SODIUM PHOSPHATE (UNII: IV021NXA9J) (PREDNISOLONE - UNII:9PHQ9Y1OLM), GATIFLOXACIN (UNII: L4618BD7KJ) (GATIFLOXACIN ANHYDROUS - UNII:81485Y3A9A), BROMFENAC (UNII: 864P0921DW) (BROMFENAC - UNII:864P0921DW)
Imprimis NJOF, LLC
OPHTHALMIC
PRESCRIPTION DRUG
unapproved drug other
PRED PHOS-GATI-BROM- PREDNISOLONE PHOSPHATE - GATIFLOXACIN - BROMFENAC SOLUTION/ DROPS IMPRIMIS NJOF, LLC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- STORE AT 20° TO 25° C (68° TO 77° F) PRED PHOS-GATI-BROM prednisolone phosphate - gatifloxacin - bromfenac solution/ drops PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:7138 4-550 ROUTE OF ADMINISTRATION OPHTHALMIC ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH PREDNISO LO NE SO DIUM PHO SPHATE (UNII: IV0 21NXA9 J) (PREDNISOLONE - UNII:9 PHQ9 Y1OLM) PREDNISOLONE 21- PHOSPHATE 10 mg in 1 mL GATIFLO XACIN (UNII: L46 18 BD7KJ) (GATIFLOXACIN ANHYDROUS - UNII:8 148 5Y3A9 A) GATIFLOXACIN 5 mg in 1 mL BRO MFENAC (UNII: 8 6 4P0 9 21DW) (BROMFENAC - UNII:8 6 4P0 9 21DW) BROMFENAC 0 .75 mg in 1 mL PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:7138 4-550 - 0 3 3.5 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n Pro duc t 0 7/0 2/20 18 2 NDC:7138 4-550 - 0 7 7 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n Pro duc t 0 7/0 2/20 18 Imprimis NJOF, LLC MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 7/0 2/20 18 LABELER - Imprimis NJOF, LLC (080431967) Revised: 6/2018 Read the complete document